Department of Clinical Science, University of Bergen, Bergen, Norway.
K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway.
Front Endocrinol (Lausanne). 2021 Oct 18;12:718660. doi: 10.3389/fendo.2021.718660. eCollection 2021.
Patients with primary adrenal insufficiency (PAI) suffer reduced quality of life (QoL), but comparisons with large-scale normative data are scarce. The clinical characteristics associated with reduced QoL are largely unknown.
Cross-sectional data on clinical characteristics and QoL scores from 494 patients were included. QoL was measured using RAND-36 (generic) and AddiQoL (-30 and -8, disease-specific). RAND-36 is reported as subdomain scores as well as physical (PCS) and metal (MCS) summary scores and compared with normative data.
Perception of physical role was consistently decreased across age groups in patients with PAI compared with normative data [75 (0-100) 100 (50-100), p<0.001]. Men with PAI reported significantly lower scores for social functioning [88 (75-100) 100 (75-100), p<0.001], as well as for vitality and physical role. In women, the greatest impairment was seen in physical role [50 (0-100) 100 (50-100), p<0.001], followed by social functioning, vitality, physical function, general health, mental health, and emotional role. Overall, better QoL was associated with male sex (AddiQoL-30: 89 ± 13 82 ± 13, p<0.002), younger age (e.g. 20-29 80-89 years: PCS 59 [50-62] 46 [37-53], p<0.001), autoimmune etiology [PCS: 53 (45-59) . 45 (38-54), p<0.001], and absence of autoimmune comorbidity [PCS: 54 (45-59) 50 (43-58), p<0.001]. There were no significant differences in QoL scores between different doses or dosing regimens of glucocorticoid or mineralocorticoid replacement.
QoL is reduced in patients with PAI, especially perception of physical role in women and social functioning in men. Among patients with PAI, female sex, higher age, non-autoimmune etiology, and autoimmune comorbidity was associated with lower QoL-scores.
原发性肾上腺功能不全 (PAI) 患者的生活质量 (QoL) 下降,但与大规模规范数据的比较却很少。与 QoL 下降相关的临床特征在很大程度上尚不清楚。
纳入 494 例患者的横断面临床特征和 QoL 评分数据。使用 RAND-36(通用)和 AddiQoL(-30 和-8,疾病特异性)来测量 QoL。RAND-36 报告为亚域评分以及身体 (PCS) 和心理 (MCS) 综合评分,并与规范数据进行比较。
与规范数据相比,PAI 患者在各个年龄组的身体角色感知均持续下降[75(0-100)100(50-100),p<0.001]。PAI 男性报告社会功能显著降低[88(75-100)100(75-100),p<0.001],以及活力和身体角色。在女性中,身体角色的损害最大[50(0-100)100(50-100),p<0.001],其次是社会功能、活力、身体功能、一般健康、心理健康和情绪角色。总体而言,更好的 QoL 与男性(AddiQoL-30:89 ± 13 82 ± 13,p<0.002)、较年轻的年龄(例如 20-29 80-89 岁:PCS 59 [50-62] 46 [37-53],p<0.001)、自身免疫病因(PCS:53(45-59). 45(38-54),p<0.001)和无自身免疫合并症(PCS:54(45-59)50(43-58),p<0.001)相关。糖皮质激素或盐皮质激素替代治疗的不同剂量或方案之间的 QoL 评分无显著差异。
PAI 患者的 QoL 下降,尤其是女性对身体角色的感知和男性的社会功能。在 PAI 患者中,女性、较高的年龄、非自身免疫病因和自身免疫合并症与较低的 QoL 评分相关。